Skip to main content

Market Overview

19 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Share:

Gainers

Medigus, Inc. (NASDAQ:MDGS) stock rose 45.73% to $4.27 during Wednesday's pre-market session.

Clovis Oncology, Inc. (NASDAQ:CLVS) shares increased by 9.86% to $8.47. The most recent rating by H.C. Wainwright, on May 6, is at Buy, with a price target of $29.

Mesoblast, Inc. (NASDAQ:MESO) shares increased by 8.11% to $11.87.

TG Therapeutics, Inc. (NASDAQ:TGTX) stock moved upwards by 7.85% to $18. The most recent rating by Cantor Fitzgerald, on May 6, is at Overweight, with a price target of $35.

InMode, Inc. (NASDAQ:INMD) shares increased by 7.77% to $28.03. The most recent rating by Barclays, on Mar 26, is at Overweight, with a price target of $36.

TherapeuticsMD, Inc. (NASDAQ:TXMD) shares rose 7.58% to $1.49. The most recent rating by Stifel, on Apr 16, is at Buy, with a price target of $15.

Lianluo Smart, Inc. (NASDAQ:LLIT) stock rose 7.34% to $0.50.

Phio Pharmaceuticals, Inc. (NASDAQ:PHIO) shares increased by 7.31% to $2.35.

Horizon Therapeutics, Inc. (NASDAQ:HZNP) stock increased by 7.01% to $40. The most recent rating by Jefferies, on Apr 28, is at Buy, with a price target of $51.

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) shares increased by 5.68% to $0.54.

 

Losers

Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) shares declined 12.58% to $0.56 during Wednesday's pre-market session.

T2 Biosystems, Inc. (NASDAQ:TTOO) shares fell 9.34% to $0.54. The most recent rating by SVB Leerink, on May 6, is at Outperform, with a price target of $2.

Silk Road Medical, Inc. (NASDAQ:SILK) stock declined 7.58% to $40. The most recent rating by Stifel, on May 1, is at Buy, with a price target of $47.

Trillium Therapeutics, Inc. (NASDAQ:TRIL) stock decreased by 6.21% to $4.98.

KemPharm, Inc. (NASDAQ:KMPH) shares decreased by 6.18% to $0.26.

Therapix Biosciences, Inc. (NASDAQ:TRPX) stock declined 5.44% to $0.33.

Akebia Therapeutics, Inc. (NASDAQ:AKBA) shares decreased by 3.77% to $11.50. The most recent rating by Needham, on May 5, is at Buy, with a price target of $18.

Dare Bioscience, Inc. (NASDAQ:DARE) stock declined 3.70% to $1.04. The most recent rating by Brookline Capital, on Apr 28, is at Buy, with a price target of $8.

Seelos Therapeutics, Inc. (NASDAQ:SEEL) shares decreased by 3.12% to $0.55.

 

Related Articles (CLVS + MDGS)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversPre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com